本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Terns Pharmaceuticals, Inc.

6.89
-0.3600-4.97%
盤後7.040.1500+2.18%19:59 EDT
成交量:126.71萬
成交額:893.05萬
市值:6.03億
市盈率:-6.61
高:7.32
開:7.24
低:6.87
收:7.25
52周最高:11.40
52周最低:1.87
股本:8,751.10萬
流通股本:5,715.62萬
量比:1.25
換手率:2.22%
股息:- -
股息率:- -
每股收益(TTM):-1.0419
每股收益(LYR):-1.1175
淨資產收益率:-35.02%
總資產收益率:-23.97%
市淨率:1.98
市盈率(LYR):-6.17

資料載入中...

2023/03/29

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/27

重要事件披露

8-K - Current report
2023/03/27

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/13

重要事件披露

8-K - Current report
2023/03/02

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/08

SEC問詢函

CORRESP [Cover] - Correspondence
2023/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/05

重要事件披露

8-K - Current report
2023/01/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/23

重要事件披露

8-K - Current report